Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HRH4 | Q9H3N8 | 5/20 | 0.42 |
| ▸ | CHKA | P35790 | 1/20 | 0.41 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | ELOVL1 | Q9BW60 | 1/20 | 0.39 |
| ▸ | CTSA | P10619 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30489430 | 0.81 | USP30 (0.47) | USP30MAPTNPC1PKMHTT | |
| SCHEMBL2533014 | 0.81 | ALDH1A1 (0.51) | USP30MAPTNPC1PKMHTT | |
| SCHEMBL10098376 | 0.80 | KDM4E (0.50) | USP30MAPTNPC1PKMHTT | |
| SCHEMBL14882630 | 0.79 | USP30 (0.52) | USP30MAPTNPC1PKMHTT | |
| Hydrochloric Acid SCHEMBL14876289 | 0.78 | KDM4E (0.49) | USP30MAPTNPC1PKMHTT | |
| SCHEMBL18135099 | 0.78 | NFKB1 (0.51) | USP30MAPTNPC1PKMHTT | |
| SCHEMBL2539328 | 0.75 | NPC1 (0.48) | USP30MAPTNPC1PKMHTT | |
| SCHEMBL14877354 | 0.75 | USP30 (0.46) | USP30MAPTNPC1PKMHTT | |
| SCHEMBL18135111 | 0.75 | HRH4 (0.48) | USP30MAPTNPC1PKMHTT | |
| SCHEMBL12720868 | 0.74 | USP30 (0.48) | USP30MAPTNPC1PKMHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8044013-B2 | Complex of manganese, titanium, nickel, copper, cobalt, iron and ligands | BASF SE (DE) | 2011-10-25 | — | — | US | disclosed |
| US-8044013-B2 | Complex of manganese, titanium, nickel, copper, cobalt, iron and ligands | BASF SE (DE) | 2011-10-25 | — | — | US | disclosed |
| US-8044013-B2 | Complex of manganese, titanium, nickel, copper, cobalt, iron and ligands | BASF SE (DE) | 2011-10-25 | — | — | US | disclosed |
| US-7692004-B2 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-04-06 | — | — | US | disclosed |
| US-7692004-B2 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-04-06 | — | — | US | disclosed |
| US-7692004-B2 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-04-06 | — | — | US | disclosed |
| US-20090189119-A1 | Use of metal complex compounds comprising pyridine pyrimidine or s-triazine derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acids and h202 | WIEPRECHT TORSTEN | 2009-07-30 | — | — | US | disclosed |
| US-20090189119-A1 | Use of metal complex compounds comprising pyridine pyrimidine or s-triazine derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acids and h202 | WIEPRECHT TORSTEN | 2009-07-30 | — | — | US | disclosed |
| US-20090189119-A1 | Use of metal complex compounds comprising pyridine pyrimidine or s-triazine derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acids and h202 | WIEPRECHT TORSTEN | 2009-07-30 | — | — | US | disclosed |
| US-20090068282-A1 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORPORATION | 2009-03-12 | — | — | US | disclosed |
| US-20080262225-A1 | Use of metal complex compounds as oxidation catalysts | SCHLINGLOFF GUNTHER | 2008-10-23 | — | — | US | disclosed |
| US-20080262225-A1 | Use of metal complex compounds as oxidation catalysts | SCHLINGLOFF GUNTHER | 2008-10-23 | — | — | US | disclosed |
| US-20080262225-A1 | Use of metal complex compounds as oxidation catalysts | SCHLINGLOFF GUNTHER | 2008-10-23 | — | — | US | disclosed |
| US-7161005-B2 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-01-09 | — | — | US | disclosed |
| US-7161005-B2 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-01-09 | — | — | US | disclosed |
| US-7161005-B2 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-01-09 | — | — | US | disclosed |
| US-20060264633-A1 | Use of metal complex compounds as oxidation catalysts | SCHLINGLOFF GUNTHER | 2006-11-23 | — | — | US | disclosed |
| EP-1383857-B1 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | CIBA SC HOLDING AG (CH) | 2006-05-31 | — | — | EP | disclosed |
| US-20060019853-A1 | Use of metal complex compounds as catalysts for oxidation using molecular oxygen or air | CIBA SPECIALTY CHEMICALS CORP. | 2006-01-26 | — | — | US | disclosed |
| US-20040142843-A1 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORP. | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264633-A1 | Use of metal complex compounds as oxidation catalysts | MICOS13, MLX, SOD1 | USP30 3490/4885MAPT 4339/4885NPC1 1281/4885 |
| US-20060019853-A1 | Use of metal complex compounds as catalysts for oxidation using molecular oxygen or air | COX14, MICOS13, OR10J3 | USP30 4192/4885MAPT 4366/4885NPC1 1005/4885 |
| US-20080262225-A1 | Use of metal complex compounds as oxidation catalysts | MICOS13, MLX, RPL13 | USP30 3654/4885MAPT 4312/4885NPC1 1458/4885 |
| US-20090068282-A1 | Use of metal complex compounds as oxidation catalysts | MICOS13, MLX, SOD1 | USP30 3661/4885MAPT 4354/4885NPC1 1390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.